

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of interferon-alpha production (GO:0032727) | 6.02023943 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 6.01887314 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 6.01887314 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.01887314 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.01887314 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.01887314 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 6.01887314 |
| 8 | cellular response to interferon-alpha (GO:0035457) | 5.99146906 |
| 9 | response to peptidoglycan (GO:0032494) | 5.78931642 |
| 10 | regulation of interferon-alpha production (GO:0032647) | 5.76508147 |
| 11 | cellular response to type I interferon (GO:0071357) | 5.68651437 |
| 12 | type I interferon signaling pathway (GO:0060337) | 5.68651437 |
| 13 | response to type I interferon (GO:0034340) | 5.61295725 |
| 14 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 5.40319018 |
| 15 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 5.40319018 |
| 16 | cellular response to exogenous dsRNA (GO:0071360) | 5.38106980 |
| 17 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.31961593 |
| 18 | response to interferon-alpha (GO:0035455) | 5.28375872 |
| 19 | * positive regulation of cAMP-mediated signaling (GO:0043950) | 5.21336214 |
| 20 | negative regulation of viral genome replication (GO:0045071) | 5.11169135 |
| 21 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.04944802 |
| 22 | regulation of type 2 immune response (GO:0002828) | 4.88490187 |
| 23 | natural killer cell activation involved in immune response (GO:0002323) | 4.85030483 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 4.78228260 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.73828949 |
| 26 | * T cell migration (GO:0072678) | 4.70246610 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69514903 |
| 28 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.69101958 |
| 29 | regulation of viral genome replication (GO:0045069) | 4.63580889 |
| 30 | cellular response to interferon-beta (GO:0035458) | 4.63528603 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 4.63169717 |
| 32 | positive regulation of type 2 immune response (GO:0002830) | 4.55793325 |
| 33 | regulation of T cell tolerance induction (GO:0002664) | 4.47948421 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 4.40663246 |
| 35 | regulation of chemokine biosynthetic process (GO:0045073) | 4.37051844 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.33537857 |
| 37 | response to host immune response (GO:0052572) | 4.33537857 |
| 38 | response to exogenous dsRNA (GO:0043330) | 4.31834395 |
| 39 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.27258386 |
| 40 | regulation of activation of Janus kinase activity (GO:0010533) | 4.25463057 |
| 41 | positive regulation of interferon-beta production (GO:0032728) | 4.21926572 |
| 42 | * lymphocyte chemotaxis (GO:0048247) | 4.19544676 |
| 43 | response to interferon-beta (GO:0035456) | 4.19405285 |
| 44 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.16443339 |
| 45 | positive regulation of heat generation (GO:0031652) | 4.14864341 |
| 46 | positive regulation of interleukin-17 production (GO:0032740) | 4.08372538 |
| 47 | defense response to protozoan (GO:0042832) | 4.04246417 |
| 48 | cellular response to virus (GO:0098586) | 4.03506228 |
| 49 | regulation of fever generation (GO:0031620) | 4.03051818 |
| 50 | response to interferon-gamma (GO:0034341) | 4.02518957 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.99498876 |
| 52 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.99447846 |
| 53 | granulocyte activation (GO:0036230) | 3.88858139 |
| 54 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.86558289 |
| 55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85906159 |
| 56 | eosinophil chemotaxis (GO:0048245) | 3.84334757 |
| 57 | T-helper 1 type immune response (GO:0042088) | 3.83957361 |
| 58 | monocyte chemotaxis (GO:0002548) | 3.82928745 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.81539349 |
| 60 | response to host (GO:0075136) | 3.81539349 |
| 61 | response to host defenses (GO:0052200) | 3.81539349 |
| 62 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.80288937 |
| 63 | regulation of mononuclear cell migration (GO:0071675) | 3.79595735 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.79086536 |
| 65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.76650191 |
| 66 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.76084215 |
| 67 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.72323490 |
| 68 | natural killer cell mediated immunity (GO:0002228) | 3.72323490 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.71752358 |
| 70 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.70996631 |
| 71 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.68324812 |
| 72 | regulation of RIG-I signaling pathway (GO:0039535) | 3.67730556 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.62954454 |
| 74 | positive regulation of interleukin-12 production (GO:0032735) | 3.60383671 |
| 75 | kynurenine metabolic process (GO:0070189) | 3.59823257 |
| 76 | detection of molecule of bacterial origin (GO:0032490) | 3.55960867 |
| 77 | regulation of immunoglobulin secretion (GO:0051023) | 3.53431755 |
| 78 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.53149030 |
| 79 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.52420057 |
| 80 | regulation of response to interferon-gamma (GO:0060330) | 3.51992134 |
| 81 | B cell mediated immunity (GO:0019724) | 3.51409960 |
| 82 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.49740865 |
| 83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.47700247 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 3.44344258 |
| 85 | indolalkylamine catabolic process (GO:0046218) | 3.44344258 |
| 86 | tryptophan catabolic process (GO:0006569) | 3.44344258 |
| 87 | respiratory burst (GO:0045730) | 3.42384587 |
| 88 | response to dsRNA (GO:0043331) | 3.42272015 |
| 89 | regulation of T cell cytokine production (GO:0002724) | 3.42067696 |
| 90 | positive regulation of tolerance induction (GO:0002645) | 3.41235280 |
| 91 | response to muramyl dipeptide (GO:0032495) | 3.41022045 |
| 92 | positive regulation of T cell cytokine production (GO:0002726) | 3.40135895 |
| 93 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40011015 |
| 94 | eosinophil migration (GO:0072677) | 3.39604480 |
| 95 | regulation of interleukin-17 production (GO:0032660) | 3.39457666 |
| 96 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.39388452 |
| 97 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.39232904 |
| 98 | regulation of interleukin-12 production (GO:0032655) | 3.38546781 |
| 99 | negative regulation of type 2 immune response (GO:0002829) | 3.38411659 |
| 100 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.38108736 |
| 101 | response to protozoan (GO:0001562) | 3.38033912 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 3.37579468 |
| 103 | microglial cell activation (GO:0001774) | 3.37154566 |
| 104 | interferon-gamma secretion (GO:0072643) | 3.36960473 |
| 105 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.36874937 |
| 106 | neutrophil activation (GO:0042119) | 3.36353962 |
| 107 | regulation of chronic inflammatory response (GO:0002676) | 3.36329370 |
| 108 | superoxide anion generation (GO:0042554) | 3.34234494 |
| 109 | myeloid dendritic cell differentiation (GO:0043011) | 3.32582084 |
| 110 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.32166549 |
| 111 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.31866809 |
| 112 | regulation of defense response to virus by host (GO:0050691) | 3.31721410 |
| 113 | regulation of T-helper cell differentiation (GO:0045622) | 3.31581171 |
| 114 | cellular response to interferon-gamma (GO:0071346) | 3.29386118 |
| 115 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.28528817 |
| 116 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27689313 |
| 117 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.27049643 |
| 118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.26276345 |
| 119 | reactive oxygen species biosynthetic process (GO:1903409) | 3.26128727 |
| 120 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.25719864 |
| 121 | myeloid cell activation involved in immune response (GO:0002275) | 3.24792654 |
| 122 | NIK/NF-kappaB signaling (GO:0038061) | 3.22487031 |
| 123 | * response to virus (GO:0009615) | 3.21397130 |
| 124 | * defense response to virus (GO:0051607) | 3.20408958 |
| 125 | positive regulation of defense response to virus by host (GO:0002230) | 3.18263351 |
| 126 | regulation of podosome assembly (GO:0071801) | 3.17810845 |
| 127 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.14330754 |
| 128 | dendritic cell differentiation (GO:0097028) | 3.13234025 |
| 129 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.12930883 |
| 130 | positive regulation of mast cell degranulation (GO:0043306) | 3.12035510 |
| 131 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.12035510 |
| 132 | negative regulation of viral process (GO:0048525) | 3.10897573 |
| 133 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10659040 |
| 134 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10659040 |
| 135 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.10338937 |
| 136 | regulation of interferon-beta production (GO:0032648) | 3.09743508 |
| 137 | regulation of heat generation (GO:0031650) | 3.08062480 |
| 138 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07933233 |
| 139 | negative regulation of type I interferon production (GO:0032480) | 3.07505260 |
| 140 | regulation of toll-like receptor signaling pathway (GO:0034121) | 3.07281794 |
| 141 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.06983125 |
| 142 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.06361839 |
| 143 | cellular response to ethanol (GO:0071361) | 3.06023930 |
| 144 | JAK-STAT cascade (GO:0007259) | 3.05875561 |
| 145 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04564370 |
| 146 | B cell proliferation (GO:0042100) | 3.04268387 |
| 147 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.03834333 |
| 148 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.03394602 |
| 149 | positive regulation of chemokine production (GO:0032722) | 3.03322337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.86664558 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.85798472 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.77599580 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.51100324 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.28223514 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.45759279 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.90205347 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.62030090 |
| 9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.47971377 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44781442 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.99239348 |
| 12 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.83184857 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83040123 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73275852 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49621147 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42775705 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42213222 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37399682 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.25781115 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25362874 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76390497 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74418134 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68982298 |
| 24 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58103795 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57524045 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56952347 |
| 27 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51279834 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50411357 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49145535 |
| 30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49106067 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47812138 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45661909 |
| 33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42306745 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38466077 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.32622375 |
| 36 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22235230 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22231927 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18568093 |
| 39 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17048824 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14913881 |
| 41 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13370058 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12854325 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.09185945 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08922615 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08053524 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05823964 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05387940 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04127223 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02996033 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02734519 |
| 51 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01768859 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.00813266 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00719765 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97883462 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96666433 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96344867 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95947118 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93783958 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91988072 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87731343 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87093319 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86854980 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85504562 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.84850702 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83247031 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82979371 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81362307 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81362307 |
| 69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80675914 |
| 70 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80171290 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 0.80017836 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76658746 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76376452 |
| 74 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.72372352 |
| 75 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.71623219 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69908249 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.69428196 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69229050 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69044837 |
| 80 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68982874 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.68834660 |
| 82 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.68138393 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 0.67658645 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.67257164 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.66901580 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65689629 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65651099 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.65194715 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64518785 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64340012 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.64028364 |
| 92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.62977103 |
| 93 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61521142 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.60812835 |
| 95 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.60715264 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.59588706 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.58954287 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58693549 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58315321 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.57982691 |
| 101 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.57305586 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.56546344 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.55707333 |
| 104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.55580358 |
| 105 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55464156 |
| 106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.55267899 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 0.55092173 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.54257133 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.53319569 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.51324675 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.51290701 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.51171935 |
| 113 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.49866548 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.49799875 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.49799875 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.49735003 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.49050772 |
| 118 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.48813513 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.48457749 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.48334900 |
| 121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.47545491 |
| 122 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.46682288 |
| 123 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.44892881 |
| 124 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.44860453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.97585302 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.44331708 |
| 3 | MP0003436_decreased_susceptibility_to | 4.00180638 |
| 4 | MP0003724_increased_susceptibility_to | 3.98183370 |
| 5 | * MP0002148_abnormal_hypersensitivity_rea | 3.95700017 |
| 6 | * MP0006082_CNS_inflammation | 3.85287293 |
| 7 | MP0003303_peritoneal_inflammation | 3.65519760 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.39444302 |
| 9 | * MP0005025_abnormal_response_to | 3.28672485 |
| 10 | MP0002419_abnormal_innate_immunity | 3.13392407 |
| 11 | MP0005387_immune_system_phenotype | 3.12188814 |
| 12 | MP0001790_abnormal_immune_system | 3.12188814 |
| 13 | MP0004510_myositis | 3.03554305 |
| 14 | MP0000685_abnormal_immune_system | 2.95997595 |
| 15 | MP0005671_abnormal_response_to | 2.67058844 |
| 16 | * MP0002723_abnormal_immune_serum | 2.57483392 |
| 17 | MP0009764_decreased_sensitivity_to | 2.55721776 |
| 18 | * MP0002452_abnormal_antigen_presenting | 2.52703660 |
| 19 | * MP0001800_abnormal_humoral_immune | 2.49031313 |
| 20 | MP0004947_skin_inflammation | 2.39393437 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.38715398 |
| 22 | * MP0001819_abnormal_immune_cell | 2.08689138 |
| 23 | MP0001853_heart_inflammation | 2.03308262 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.01106557 |
| 25 | * MP0002420_abnormal_adaptive_immunity | 2.00761456 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.94897714 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.94591140 |
| 28 | * MP0008469_abnormal_protein_level | 1.90102749 |
| 29 | MP0003075_altered_response_to | 1.88233815 |
| 30 | MP0002006_tumorigenesis | 1.86343074 |
| 31 | MP0003448_altered_tumor_morphology | 1.83544611 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.80434467 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.78217305 |
| 34 | MP0005451_abnormal_body_composition | 1.75220298 |
| 35 | MP0005310_abnormal_salivary_gland | 1.69309604 |
| 36 | MP0009278_abnormal_bone_marrow | 1.66287847 |
| 37 | MP0000343_altered_response_to | 1.66005761 |
| 38 | MP0002405_respiratory_system_inflammati | 1.58993647 |
| 39 | MP0004858_abnormal_nervous_system | 1.54864327 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.53769231 |
| 41 | MP0003690_abnormal_glial_cell | 1.47790228 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.47219668 |
| 43 | * MP0000716_abnormal_immune_system | 1.42120677 |
| 44 | MP0009840_abnormal_foam_cell | 1.40916453 |
| 45 | MP0000604_amyloidosis | 1.38525766 |
| 46 | MP0006054_spinal_hemorrhage | 1.37162571 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.36311867 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.36110584 |
| 49 | MP0005164_abnormal_response_to | 1.34859243 |
| 50 | MP0005166_decreased_susceptibility_to | 1.32285863 |
| 51 | MP0002398_abnormal_bone_marrow | 1.32281439 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.27826939 |
| 53 | MP0004782_abnormal_surfactant_physiolog | 1.27351601 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.26113633 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.26113633 |
| 56 | MP0000858_altered_metastatic_potential | 1.23417813 |
| 57 | MP0009763_increased_sensitivity_to | 1.22121467 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.20296708 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.18156679 |
| 60 | MP0002254_reproductive_system_inflammat | 1.11160261 |
| 61 | MP0005390_skeleton_phenotype | 1.09924035 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.09640181 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.08029424 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 1.07375185 |
| 65 | * MP0002429_abnormal_blood_cell | 1.06867681 |
| 66 | MP0003186_abnormal_redox_activity | 1.06405508 |
| 67 | MP0002163_abnormal_gland_morphology | 1.04214390 |
| 68 | MP0002332_abnormal_exercise_endurance | 0.98703105 |
| 69 | MP0003195_calcinosis | 0.98631740 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 0.97776691 |
| 71 | MP0000689_abnormal_spleen_morphology | 0.97631529 |
| 72 | MP0010307_abnormal_tumor_latency | 0.95914057 |
| 73 | MP0002166_altered_tumor_susceptibility | 0.91971215 |
| 74 | MP0002722_abnormal_immune_system | 0.90549459 |
| 75 | MP0001851_eye_inflammation | 0.88834931 |
| 76 | MP0008874_decreased_physiological_sensi | 0.79211106 |
| 77 | MP0003828_pulmonary_edema | 0.77095864 |
| 78 | * MP0000920_abnormal_myelination | 0.75466470 |
| 79 | * MP0009333_abnormal_splenocyte_physiolog | 0.73275611 |
| 80 | MP0003045_fibrosis | 0.73255199 |
| 81 | MP0003091_abnormal_cell_migration | 0.72819948 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.69681805 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.68522786 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 0.67898244 |
| 85 | MP0003763_abnormal_thymus_physiology | 0.67094709 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.65848810 |
| 87 | MP0000249_abnormal_blood_vessel | 0.65500127 |
| 88 | MP0002933_joint_inflammation | 0.64597011 |
| 89 | MP0005083_abnormal_biliary_tract | 0.63795261 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.61988916 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.61866342 |
| 92 | MP0005165_increased_susceptibility_to | 0.61198983 |
| 93 | MP0001663_abnormal_digestive_system | 0.60788467 |
| 94 | MP0001873_stomach_inflammation | 0.59056658 |
| 95 | MP0003866_abnormal_defecation | 0.58925023 |
| 96 | MP0000609_abnormal_liver_physiology | 0.58271363 |
| 97 | MP0008438_abnormal_cutaneous_collagen | 0.58217553 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.58160029 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.58116070 |
| 100 | MP0005535_abnormal_body_temperature | 0.57091734 |
| 101 | MP0003646_muscle_fatigue | 0.56915062 |
| 102 | MP0008004_abnormal_stomach_pH | 0.55465110 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.54078849 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.53707622 |
| 105 | MP0003950_abnormal_plasma_membrane | 0.53196327 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.49762188 |
| 107 | MP0004808_abnormal_hematopoietic_stem | 0.49408841 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.49246088 |
| 109 | MP0003795_abnormal_bone_structure | 0.48315562 |
| 110 | MP0005023_abnormal_wound_healing | 0.48252798 |
| 111 | MP0005647_abnormal_sex_gland | 0.47511324 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.47277336 |
| 113 | MP0004883_abnormal_blood_vessel | 0.45979313 |
| 114 | MP0001881_abnormal_mammary_gland | 0.45584264 |
| 115 | MP0001348_abnormal_lacrimal_gland | 0.45537943 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.43860749 |
| 117 | MP0008260_abnormal_autophagy | 0.43666094 |
| 118 | MP0003329_amyloid_beta_deposits | 0.43383422 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.43158176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.14425527 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.84789062 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.79997880 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.91114030 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.84040406 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 5.80128831 |
| 7 | Increased IgM level (HP:0003496) | 5.58453893 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 5.55777337 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.13892713 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.99818500 |
| 11 | Stomatitis (HP:0010280) | 4.53173036 |
| 12 | Basal ganglia calcification (HP:0002135) | 4.44738486 |
| 13 | Orchitis (HP:0100796) | 4.43024461 |
| 14 | Vasculitis (HP:0002633) | 4.30163418 |
| 15 | Myositis (HP:0100614) | 4.18849492 |
| 16 | Gingivitis (HP:0000230) | 4.15763465 |
| 17 | Recurrent skin infections (HP:0001581) | 4.14913263 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 4.05726980 |
| 19 | Optic neuritis (HP:0100653) | 4.05726980 |
| 20 | Thick nail (HP:0001805) | 3.69104934 |
| 21 | Hypergammaglobulinemia (HP:0010702) | 3.66472201 |
| 22 | Interstitial pulmonary disease (HP:0006530) | 3.62628976 |
| 23 | Loss of speech (HP:0002371) | 3.60625987 |
| 24 | Porencephaly (HP:0002132) | 3.55605000 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.55303566 |
| 26 | Cheilitis (HP:0100825) | 3.52743710 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.50229048 |
| 28 | Tetraparesis (HP:0002273) | 3.40751174 |
| 29 | Periodontitis (HP:0000704) | 3.33689072 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 3.32457783 |
| 31 | T lymphocytopenia (HP:0005403) | 3.28393298 |
| 32 | Pustule (HP:0200039) | 3.27798054 |
| 33 | Recurrent viral infections (HP:0004429) | 3.26217843 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.24092664 |
| 35 | Obstructive lung disease (HP:0006536) | 3.24092664 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 3.22834753 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.19425109 |
| 38 | Prostate neoplasm (HP:0100787) | 3.12277875 |
| 39 | Chronic otitis media (HP:0000389) | 3.10830143 |
| 40 | Poor head control (HP:0002421) | 3.03418684 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.00978426 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 2.97479219 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.94091841 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.89712876 |
| 45 | Urticaria (HP:0001025) | 2.86926965 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.85295771 |
| 47 | Axonal loss (HP:0003447) | 2.82785049 |
| 48 | Premature loss of primary teeth (HP:0006323) | 2.80588647 |
| 49 | Abnormality of the endocardium (HP:0004306) | 2.80062757 |
| 50 | Abnormality of the pericardium (HP:0001697) | 2.77369984 |
| 51 | Cellulitis (HP:0100658) | 2.75373251 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69790131 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69790131 |
| 54 | Encephalitis (HP:0002383) | 2.66830092 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.66559430 |
| 56 | Disinhibition (HP:0000734) | 2.65881728 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.64088746 |
| 58 | Recurrent pneumonia (HP:0006532) | 2.59763150 |
| 59 | Cleft eyelid (HP:0000625) | 2.59640212 |
| 60 | Glomerulonephritis (HP:0000099) | 2.59155500 |
| 61 | Petechiae (HP:0000967) | 2.58642270 |
| 62 | Purpura (HP:0000979) | 2.56149334 |
| 63 | Nephritis (HP:0000123) | 2.55882274 |
| 64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45200016 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.45200016 |
| 66 | Joint swelling (HP:0001386) | 2.43347742 |
| 67 | Lower limb hyperreflexia (HP:0002395) | 2.40540525 |
| 68 | Recurrent lower respiratory tract infections (HP:0002783) | 2.39932863 |
| 69 | Leukocytosis (HP:0001974) | 2.39881245 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.39724238 |
| 71 | Prolonged neonatal jaundice (HP:0006579) | 2.39021300 |
| 72 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38347134 |
| 73 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37113783 |
| 74 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37113783 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37113783 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.36917783 |
| 77 | Hemoptysis (HP:0002105) | 2.34321772 |
| 78 | Hemorrhage of the eye (HP:0011885) | 2.34107503 |
| 79 | Nausea (HP:0002018) | 2.33661934 |
| 80 | Complement deficiency (HP:0004431) | 2.31270009 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.29225730 |
| 82 | Anorexia (HP:0002039) | 2.28502695 |
| 83 | Gingival bleeding (HP:0000225) | 2.28362651 |
| 84 | Pulmonary embolism (HP:0002204) | 2.28201551 |
| 85 | Keratoconjunctivitis (HP:0001096) | 2.28180407 |
| 86 | Arterial thrombosis (HP:0004420) | 2.28063620 |
| 87 | B lymphocytopenia (HP:0010976) | 2.28042269 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27939402 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27939402 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27939402 |
| 91 | Parakeratosis (HP:0001036) | 2.27086615 |
| 92 | Nasal polyposis (HP:0100582) | 2.26983739 |
| 93 | Peritonitis (HP:0002586) | 2.25090262 |
| 94 | Meningitis (HP:0001287) | 2.24336224 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23930509 |
| 96 | Polyneuropathy (HP:0001271) | 2.23361180 |
| 97 | Vertigo (HP:0002321) | 2.23077394 |
| 98 | Amyloidosis (HP:0011034) | 2.21752907 |
| 99 | Mutism (HP:0002300) | 2.20487253 |
| 100 | Progressive neurologic deterioration (HP:0002344) | 2.18584065 |
| 101 | Progressive visual loss (HP:0000529) | 2.18117682 |
| 102 | Malnutrition (HP:0004395) | 2.17160207 |
| 103 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16275653 |
| 104 | Mucopolysacchariduria (HP:0008155) | 2.16275653 |
| 105 | Esophageal neoplasm (HP:0100751) | 2.15148800 |
| 106 | Neoplasm of head and neck (HP:0012288) | 2.15148800 |
| 107 | Colitis (HP:0002583) | 2.14586353 |
| 108 | Arthralgia (HP:0002829) | 2.13957806 |
| 109 | Osteomyelitis (HP:0002754) | 2.12456846 |
| 110 | Hematochezia (HP:0002573) | 2.10608112 |
| 111 | Bone pain (HP:0002653) | 2.09693428 |
| 112 | Memory impairment (HP:0002354) | 2.08025863 |
| 113 | Glomerulopathy (HP:0100820) | 2.07898780 |
| 114 | Stomach cancer (HP:0012126) | 2.07822601 |
| 115 | Pigmentary retinal degeneration (HP:0001146) | 2.06925661 |
| 116 | Gangrene (HP:0100758) | 2.06566514 |
| 117 | Amaurosis fugax (HP:0100576) | 2.05373695 |
| 118 | Abnormality of T cells (HP:0002843) | 2.04276340 |
| 119 | Keratitis (HP:0000491) | 2.04098589 |
| 120 | Chest pain (HP:0100749) | 2.04029703 |
| 121 | Myocardial infarction (HP:0001658) | 2.03942340 |
| 122 | Abnormality of the nasal mucosa (HP:0000433) | 2.03131781 |
| 123 | Eosinophilia (HP:0001880) | 2.01402033 |
| 124 | Skin ulcer (HP:0200042) | 2.00640272 |
| 125 | Plagiocephaly (HP:0001357) | 2.00552812 |
| 126 | Abnormality of the basal ganglia (HP:0002134) | 1.97036797 |
| 127 | Abnormality of the prostate (HP:0008775) | 1.96590749 |
| 128 | Skin rash (HP:0000988) | 1.95742670 |
| 129 | IgA deficiency (HP:0002720) | 1.95190178 |
| 130 | Neurofibrillary tangles (HP:0002185) | 1.95100973 |
| 131 | Albinism (HP:0001022) | 1.94846083 |
| 132 | Vertebral compression fractures (HP:0002953) | 1.93399199 |
| 133 | Recurrent bronchitis (HP:0002837) | 1.93232238 |
| 134 | Pathologic fracture (HP:0002756) | 1.92696943 |
| 135 | Spastic tetraparesis (HP:0001285) | 1.90860295 |
| 136 | Increased serum ferritin (HP:0003281) | 1.90709172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.73619158 |
| 2 | PBK | 4.58001915 |
| 3 | TBK1 | 4.15934051 |
| 4 | TYK2 | 3.88053406 |
| 5 | RIPK4 | 3.82541545 |
| 6 | BLK | 3.52166147 |
| 7 | IKBKE | 3.44451133 |
| 8 | IRAK4 | 3.35753343 |
| 9 | IRAK3 | 2.88903774 |
| 10 | JAK3 | 2.79395779 |
| 11 | PIM2 | 2.56003195 |
| 12 | JAK1 | 2.53955996 |
| 13 | ERN1 | 2.43248496 |
| 14 | TXK | 2.43187364 |
| 15 | IKBKB | 2.39132870 |
| 16 | MAP3K13 | 2.32141302 |
| 17 | PRPF4B | 1.79657294 |
| 18 | KIT | 1.78852122 |
| 19 | MAP4K1 | 1.77448155 |
| 20 | CSK | 1.65285591 |
| 21 | BMPR2 | 1.59210293 |
| 22 | MATK | 1.51551782 |
| 23 | FGFR4 | 1.51528813 |
| 24 | BMX | 1.48545521 |
| 25 | CHUK | 1.46363986 |
| 26 | FGR | 1.44643297 |
| 27 | TAOK2 | 1.37074473 |
| 28 | MAP3K5 | 1.35232477 |
| 29 | IRAK1 | 1.32309727 |
| 30 | MST4 | 1.31865456 |
| 31 | NEK9 | 1.29908038 |
| 32 | SYK | 1.28523648 |
| 33 | RPS6KA4 | 1.26204074 |
| 34 | ZAP70 | 1.24341160 |
| 35 | HCK | 1.21302117 |
| 36 | ARAF | 1.20643958 |
| 37 | EPHA3 | 1.14808819 |
| 38 | EIF2AK2 | 1.13489163 |
| 39 | SIK3 | 1.12109582 |
| 40 | IRAK2 | 1.10439075 |
| 41 | MARK3 | 1.09524133 |
| 42 | EPHB1 | 1.08591997 |
| 43 | JAK2 | 1.04525631 |
| 44 | ABL2 | 1.02895162 |
| 45 | LYN | 1.01220347 |
| 46 | CDC42BPA | 0.95175583 |
| 47 | PIM1 | 0.92991598 |
| 48 | FGFR3 | 0.90891723 |
| 49 | SIK2 | 0.87694266 |
| 50 | LCK | 0.84928553 |
| 51 | STK4 | 0.79441823 |
| 52 | MAP3K3 | 0.74233713 |
| 53 | PRKCD | 0.72030181 |
| 54 | MST1R | 0.71188244 |
| 55 | TNK2 | 0.66224875 |
| 56 | ERBB3 | 0.65726700 |
| 57 | HIPK2 | 0.64862860 |
| 58 | TAOK1 | 0.62796020 |
| 59 | TGFBR2 | 0.60878587 |
| 60 | GRK7 | 0.60774466 |
| 61 | ABL1 | 0.60561866 |
| 62 | TYRO3 | 0.60490565 |
| 63 | ADRBK2 | 0.58978949 |
| 64 | PLK2 | 0.58636410 |
| 65 | NME2 | 0.58436059 |
| 66 | CSF1R | 0.56903839 |
| 67 | EGFR | 0.53450112 |
| 68 | DAPK3 | 0.53300317 |
| 69 | BTK | 0.52861042 |
| 70 | TESK2 | 0.51958316 |
| 71 | YES1 | 0.51323438 |
| 72 | TESK1 | 0.49813575 |
| 73 | PRKCQ | 0.49328903 |
| 74 | STK3 | 0.49052106 |
| 75 | FES | 0.43586291 |
| 76 | MOS | 0.40746796 |
| 77 | BCR | 0.39036897 |
| 78 | ERBB4 | 0.38725034 |
| 79 | TRPM7 | 0.38365346 |
| 80 | CLK1 | 0.38312508 |
| 81 | TAOK3 | 0.37447448 |
| 82 | STK10 | 0.36599436 |
| 83 | MAP3K12 | 0.34941484 |
| 84 | RIPK1 | 0.34066030 |
| 85 | CAMK2G | 0.33823865 |
| 86 | PLK4 | 0.32362836 |
| 87 | CDK4 | 0.31892585 |
| 88 | ITK | 0.30395841 |
| 89 | KSR2 | 0.30312794 |
| 90 | MAP3K1 | 0.29824762 |
| 91 | TEC | 0.29657451 |
| 92 | PDGFRA | 0.28454178 |
| 93 | MAP3K9 | 0.28138874 |
| 94 | LATS2 | 0.27804920 |
| 95 | FYN | 0.27083651 |
| 96 | MAPK7 | 0.25969692 |
| 97 | SIK1 | 0.25743370 |
| 98 | DYRK3 | 0.25702945 |
| 99 | MAPKAPK2 | 0.22965624 |
| 100 | MAP2K3 | 0.22953517 |
| 101 | RPS6KA5 | 0.22902372 |
| 102 | DDR2 | 0.21580089 |
| 103 | STK24 | 0.20011027 |
| 104 | DAPK2 | 0.19008223 |
| 105 | PDPK1 | 0.18602318 |
| 106 | DYRK1B | 0.17816238 |
| 107 | IGF1R | 0.17182777 |
| 108 | SRC | 0.16094245 |
| 109 | BMPR1B | 0.15146838 |
| 110 | PKN1 | 0.15096968 |
| 111 | MAP3K11 | 0.14511167 |
| 112 | PDK1 | 0.13983387 |
| 113 | PRKCE | 0.13871859 |
| 114 | INSR | 0.13718393 |
| 115 | NLK | 0.13625709 |
| 116 | LRRK2 | 0.13199249 |
| 117 | MAPK11 | 0.12204928 |
| 118 | CAMKK2 | 0.11947546 |
| 119 | MAPK3 | 0.11798490 |
| 120 | ACVR1B | 0.11367009 |
| 121 | RPS6KA1 | 0.09839793 |
| 122 | MELK | 0.09656273 |
| 123 | MAPK4 | 0.09291953 |
| 124 | CDK6 | 0.08329663 |
| 125 | PDGFRB | 0.04388992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.17418504 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.55720409 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.31366474 |
| 4 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.11930820 |
| 5 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.07585254 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.87136508 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.78719121 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.73582039 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.66716735 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.63986759 |
| 11 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.60308171 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.58274101 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.56317958 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.48916026 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.47787347 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.45725007 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36153799 |
| 18 | Measles_Homo sapiens_hsa05162 | 2.30772762 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28032510 |
| 20 | * Influenza A_Homo sapiens_hsa05164 | 2.21522099 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 2.06338967 |
| 22 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.04862496 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04393462 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.91796146 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.83643046 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.62838479 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59415912 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55415108 |
| 29 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46700825 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.27999487 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26496244 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25512876 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.23887547 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.19805251 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19482415 |
| 36 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17696927 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15593914 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.14480068 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.13395532 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.10483036 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09176285 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.03196230 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98215121 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 0.98132678 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92756066 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90183645 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80371239 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74351693 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73203597 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72364902 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67698052 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63507925 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59319215 |
| 54 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55723933 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54628436 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54442803 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49630779 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47479882 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47080626 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44720886 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43706756 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41839947 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38044486 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37690639 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37595637 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36213551 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35679748 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35667384 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35431935 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.34766979 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34390636 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34123956 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.32712076 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30422589 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30254844 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28384203 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27574206 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.26091474 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26020591 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25802045 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25194788 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23738467 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20228331 |
| 84 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.19592221 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19097349 |
| 86 | Proteasome_Homo sapiens_hsa03050 | 0.17833973 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17479798 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.15070162 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14819241 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.13842718 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.12969258 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12940407 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.11886391 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.09466005 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.09444579 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.06965472 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.06148365 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04659178 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.04461035 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.04334764 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04263550 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.03098600 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.02033521 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.01938535 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.0738190 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0705240 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | -0.0399039 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | -0.0272856 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0169355 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0161092 |

